Key financials

In the first half of the 2023/24 financial year, we have continued to implement our growth strategy successfully and consistently. We achieved consolidated sales of CHF 255.4 million. Adjusted for the divestment of Dia-Expert, this corresponds to comparable growth of 24 % for the continued business.

Next event


Investor and Analysts‘ conference for 2023/24 full-year results

Ypsomed share YPSN

Investor Fact Sheet

Ypsomed key finacial highlights at a glance.

News Service

Subscribe to our mailing list in order to receive ad hoc announcements pursuant to Art. 53 LR and further information.